502 followers
New NNT→A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple… https://t.co/b8gVyuYvsl
New NNT→A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple… https://t.co/b8gVyuYvsl
A #pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of #multiplesclerosis https://t.co/KCGcXlmChk https://t.co/uVxyV7U9VX
A #pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of #multiplesclerosis https://t.co/KCGcXlmChk https://t.co/U3ikNJcpKW
Published yesterday on @WorldMSDay https://t.co/lEyCMMEZqV